Home > Research > Publications & Outputs > A systematic content analysis of policy barrier...

Links

Text available via DOI:

View graph of relations

A systematic content analysis of policy barriers impeding access to opioid medication in Central and Eastern Europe: results of ATOME

Research output: Contribution to journalJournal articlepeer-review

Published

Standard

A systematic content analysis of policy barriers impeding access to opioid medication in Central and Eastern Europe : results of ATOME. / Larjow, Eugenia; Papavasiliou, Evie; Payne, Sheila Alison; Scholten, Willem; Radbruch, Lukas.

In: Journal of Pain and Symptom Management, Vol. 51, No. 1, 01.2016, p. 99-107.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Larjow, E, Papavasiliou, E, Payne, SA, Scholten, W & Radbruch, L 2016, 'A systematic content analysis of policy barriers impeding access to opioid medication in Central and Eastern Europe: results of ATOME', Journal of Pain and Symptom Management, vol. 51, no. 1, pp. 99-107. https://doi.org/10.1016/j.jpainsymman.2015.08.012

APA

Vancouver

Author

Larjow, Eugenia ; Papavasiliou, Evie ; Payne, Sheila Alison ; Scholten, Willem ; Radbruch, Lukas. / A systematic content analysis of policy barriers impeding access to opioid medication in Central and Eastern Europe : results of ATOME. In: Journal of Pain and Symptom Management. 2016 ; Vol. 51, No. 1. pp. 99-107.

Bibtex

@article{0fd53a575ad14d2f805bf9eff842173c,
title = "A systematic content analysis of policy barriers impeding access to opioid medication in Central and Eastern Europe: results of ATOME",
abstract = "ContextReliable access to opioid medication is critical to delivering effective pain management, adequate treatment of opioid dependence, and quality palliative care. However, more than 80% of the world population is estimated to be inadequately treated for pain because of difficulties in accessing opioids. Although barriers to opioid access are primarily associated with restrictive laws, regulations, and licensing requirements, a key problem that significantly limits opioid access relates to policy constraints.ObjectivesTo identify and explore policy barriers to opioid access in 12 Eastern and Central European countries involved in the Access to Opioid Medication in Europe project, funded by the European Community's Seventh Framework (FP7/2007–2013, no. 222994) Programme.MethodsA systematic content analysis of texts retrieved from documents (e.g., protocols of national problem analyses, strategic planning worksheets, and executive summaries) compiled, reviewed, approved, and submitted by either the Access to Opioid Medication in Europe consortium or the national country teams (comprising experts in pain management, harm reduction, and palliative care) between September 2011 and April 2014 was performed.ResultsTwenty-five policy barriers were identified (e.g., economic crisis, bureaucratic issues, lack of training initiatives, stigma, and discrimination), classified under four predetermined categories (financial/economic aspects and governmental support, formularies, education and training, and societal attitudes). Key barriers related to issues of funding allocation, affordability, knowledge, and fears associated with opioids.ConclusionReducing barriers and improving access to opioids require policy reform at the governmental level with a set of action plans being formulated and concurrently implemented and aimed at different levels of social, education, and economic policy change.",
keywords = "Opioids, policy barriers, pain management, harm reduction, palliative care",
author = "Eugenia Larjow and Evie Papavasiliou and Payne, {Sheila Alison} and Willem Scholten and Lukas Radbruch",
year = "2016",
month = jan,
doi = "10.1016/j.jpainsymman.2015.08.012",
language = "English",
volume = "51",
pages = "99--107",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - A systematic content analysis of policy barriers impeding access to opioid medication in Central and Eastern Europe

T2 - results of ATOME

AU - Larjow, Eugenia

AU - Papavasiliou, Evie

AU - Payne, Sheila Alison

AU - Scholten, Willem

AU - Radbruch, Lukas

PY - 2016/1

Y1 - 2016/1

N2 - ContextReliable access to opioid medication is critical to delivering effective pain management, adequate treatment of opioid dependence, and quality palliative care. However, more than 80% of the world population is estimated to be inadequately treated for pain because of difficulties in accessing opioids. Although barriers to opioid access are primarily associated with restrictive laws, regulations, and licensing requirements, a key problem that significantly limits opioid access relates to policy constraints.ObjectivesTo identify and explore policy barriers to opioid access in 12 Eastern and Central European countries involved in the Access to Opioid Medication in Europe project, funded by the European Community's Seventh Framework (FP7/2007–2013, no. 222994) Programme.MethodsA systematic content analysis of texts retrieved from documents (e.g., protocols of national problem analyses, strategic planning worksheets, and executive summaries) compiled, reviewed, approved, and submitted by either the Access to Opioid Medication in Europe consortium or the national country teams (comprising experts in pain management, harm reduction, and palliative care) between September 2011 and April 2014 was performed.ResultsTwenty-five policy barriers were identified (e.g., economic crisis, bureaucratic issues, lack of training initiatives, stigma, and discrimination), classified under four predetermined categories (financial/economic aspects and governmental support, formularies, education and training, and societal attitudes). Key barriers related to issues of funding allocation, affordability, knowledge, and fears associated with opioids.ConclusionReducing barriers and improving access to opioids require policy reform at the governmental level with a set of action plans being formulated and concurrently implemented and aimed at different levels of social, education, and economic policy change.

AB - ContextReliable access to opioid medication is critical to delivering effective pain management, adequate treatment of opioid dependence, and quality palliative care. However, more than 80% of the world population is estimated to be inadequately treated for pain because of difficulties in accessing opioids. Although barriers to opioid access are primarily associated with restrictive laws, regulations, and licensing requirements, a key problem that significantly limits opioid access relates to policy constraints.ObjectivesTo identify and explore policy barriers to opioid access in 12 Eastern and Central European countries involved in the Access to Opioid Medication in Europe project, funded by the European Community's Seventh Framework (FP7/2007–2013, no. 222994) Programme.MethodsA systematic content analysis of texts retrieved from documents (e.g., protocols of national problem analyses, strategic planning worksheets, and executive summaries) compiled, reviewed, approved, and submitted by either the Access to Opioid Medication in Europe consortium or the national country teams (comprising experts in pain management, harm reduction, and palliative care) between September 2011 and April 2014 was performed.ResultsTwenty-five policy barriers were identified (e.g., economic crisis, bureaucratic issues, lack of training initiatives, stigma, and discrimination), classified under four predetermined categories (financial/economic aspects and governmental support, formularies, education and training, and societal attitudes). Key barriers related to issues of funding allocation, affordability, knowledge, and fears associated with opioids.ConclusionReducing barriers and improving access to opioids require policy reform at the governmental level with a set of action plans being formulated and concurrently implemented and aimed at different levels of social, education, and economic policy change.

KW - Opioids

KW - policy barriers

KW - pain management

KW - harm reduction

KW - palliative care

U2 - 10.1016/j.jpainsymman.2015.08.012

DO - 10.1016/j.jpainsymman.2015.08.012

M3 - Journal article

VL - 51

SP - 99

EP - 107

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 1

ER -